Clinical trial Recruiting at 1 site Interventional Ages 18 to 64

Weight loss and dietary changes to prevent Alzheimer's in adults with Down syndrome

Official title: The Impact of Weight Loss on Alzheimer's Disease Risk in Adults With Down Syndrome

Run by University of Kansas Medical Center · NCT05985486 · Data updated 2026-11-12

This study is testing if losing weight or changing diets can help prevent or delay Alzheimer's in adults with Down syndrome.

More Obesity trials

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment81 (estimated)
SponsorUniversity of Kansas Medical Center
Academic / other
Locations1 site (Kansas City, Kansas)
StatusRecruiting
StartedOctober 22, 2024
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedMarch 11, 2026
Trial IDNCT05985486 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with Down syndrome who have a BMI between 25 and 50 and can communicate verbally.

Probably not a fit

Patients with a diagnosis of dementia or serious medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate whether weight loss or dietary changes can help prevent or delay the onset of Alzheimer's Disease in adults with Down syndrome. Participants will be randomly assigned to either a weight loss group, which will follow a reduced energy diet and attend monthly remote education sessions, or a control group receiving general health education. Over the course of 12 months, all participants will visit the University of Kansas Medical Center three times for assessments including blood draws, cognitive testing, MRI scans, and evaluations of diet and body weight.

Why it matters

Potential benefit: If successful, this study could provide a new approach to delaying Alzheimer's Disease in adults with Down syndrome through lifestyle modifications.

How similar studies have gone: While there have been studies on lifestyle changes in other populations, this specific approach in adults with Down syndrome is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of Down syndrome
* BMI of 25 to 50 kg/m2
* Ability to communicate through spoken language.
* Ability to come to the University of Kansas Medical Center 3 times across 1 year for outcomes testing
* Living at home with a parent/guardian, or in a supported living environment with a caregiver who assists with food shopping, meal planning, and meal preparation and agrees to serve as a study partner including providing transportation to our facilities for study assessments.

Exclusion Criteria:

* Diagnosis of dementia
* Insulin dependent diabetes
* Participation in a weight management program involving diet or physical activity in the past 6 mos.
* Dairy allergy
* Serious medical risk (e.g., cancer, recent heart attack, stroke, pregnancy, angioplasty)
* Unwilling to be randomized
* Contraindications for MRI, including metal implants or devices incompatible with MRI such as pacemakers, claustrophobia, and inability to lay in a supine position
* Use of GLP-1 medications
* Use of anti-amyloid medications

Where it's running

  • University of Kansas Medical Center
    Kansas City, Kansas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.